State Street Corp Updates Passive Stake in INSMED Inc.

Ticker: INSM · Form: SC 13G/A · Filed: 2024-01-22T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, passive-investment, amendment, healthcare

TL;DR

**State Street still owns INSMED shares, no big changes.**

AI Summary

State Street Corporation, a major financial institution, filed an updated SC 13G/A on January 22, 2024, disclosing its ownership of INSMED Inc. common stock as of December 31, 2023. This filing indicates that State Street continues to hold a significant, though passive, stake in INSMED. For investors, this means a large institutional investor maintains confidence in INSMED, which can be a positive signal, but it doesn't suggest any immediate strategic changes or activist involvement.

Why It Matters

This filing confirms State Street Corporation's continued, passive institutional ownership in INSMED Inc., signaling ongoing investor confidence without any intent for control or influence.

Risk Assessment

Risk Level: low — This filing is routine and indicates a passive investment, posing minimal new risk to INSMED shareholders.

Analyst Insight

Investors should note that a major institutional investor like State Street maintains a position, which can be a sign of stability, but this filing doesn't suggest any new catalysts or changes in company direction.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What is the purpose of an SC 13G/A filing?

An SC 13G/A is an amendment to a Schedule 13G, which is filed by institutional investors who acquire more than 5% of a company's stock but do not intend to influence or control the company. The '/A' indicates it's an amendment to a previously filed statement, updating the information.

Who is the reporting person in this filing?

The reporting person in this filing is State Street Corporation, identified by its name and IRS Identification No. 04-2456637.

What is the subject company whose shares are being reported?

The subject company is INSMED Inc., identified by its name and CUSIP Number 457669307 for its common stock.

What was the date of the event that triggered this filing?

The date of the event which requires the filing of this statement was December 31, 2023, as stated in the filing.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13D-1 (B), as indicated by the 'X' next to 'RULE 13D-1 (B)' in the filing.

From the Filing

EDGAR Filing Documents for 0000093751-24-000055 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000093751-24-000055 Filing Date 2024-01-22 Accepted 2024-01-22 12:07:03 Documents 1 Document Format Files Seq Description Document Type Size 1 Insmed_Inc.txt SC 13G/A 6505 Complete submission text file 0000093751-24-000055.txt 8504 Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000 STATE STREET CORP (Filed by) CIK : 0000093751 (see all company filings) EIN. : 042456637 | State of Incorp.: MA | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6022 State Commercial Banks (CF Office: 02 Finance) Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900 INSMED Inc (Subject) CIK : 0001104506 (see all company filings) EIN. : 541972729 | State of Incorp.: VA | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-59149 | Film No.: 24547708 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

View on Read The Filing